Partilhar
Informação da revista
Os mais lidos
9150
Cardiopulmonary exercise testing in clinical practice: Principles, applications, and basic interpretationHélder Dores, Miguel Mendes, Ana Abreu, Anaí Durazzo, Cidália Rodrigues, Eduardo Vilela, Gonçalo Cunha, José Gomes Pereira, ... Mário Santos
Rev Port Cardiol. 2024;43:525-36
9150
Acesso de texto completo
5869
Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of CardiologyMiguel Nobre Menezes, Marta Tavares da Silva, Andreia Magalhães, Bruno Melica, Júlia Cristina Toste, Rita Calé, Manuel Almeida, Manuela Fiuza, Eduardo Infante de Oliveira
Rev Port Cardiol. 2024;43:35-48
5869
Acesso de texto completo
4122
Cardiovascular benefits of resistance exercise: It's time to prescribeHélder Dores, Mafalda Antunes, Daniel Caldeira, Hugo V. Pereira
Rev Port Cardiol. 2024;43:573-82
4122
Acesso de texto completo
4071
Cardiovascular risk assessment using SCORE2 in a population with hypertension – The reality at a primary health care unitSara Pereira Santos, Sara Guedes, Ricardo Pesqueira, João Stuart, Ana M. Carvalho, Patrícia Correia, Isabel Lourenço Ribeiro, Ângela M. Teixeira
Rev Port Cardiol. 2024;43:601-10
4071
Acesso de texto completo
3708
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneRodolfo P. Rothlin, Facundo Pelorosso, Mariano Duarte, Liliana Nicolosi, Ignacio Fernandez Criado, María Victoria Salgado, Héctor Vetulli
Rev Port Cardiol. 2024;43:219-20
3708
Acesso de texto completo
3618
Cardiovascular risk assessment in Portugal's primary health care system: SCORE vs. SCORE2Cristina Silva, José Eduardo Mendes, Ricardo Ramos, Amélia Gaspar, Filipe Leal, Nuno Mendes
Rev Port Cardiol. 2024;43:449-55
3618
Acesso de texto completo
3361
conTemporary reflectiOns regarding heart failure manaGEmenT – How to ovERcome the PorTuguese barriers (TOGETHER-PT)José Silva-Cardoso, Jonathan Santos, Inês Araújo, Aurora Andrade, Pedro Morais Sarmento, Paulo Santos, Brenda Moura, Irene Marques, ... Joana Pimenta
Rev Port Cardiol. 2024;43:225-35
3361
Acesso de texto completo
3211
Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the oneJorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
Rev Port Cardiol. 2024;43:221-2
3211
Acesso de texto completo
3092
Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitusHugo Costa, Miguel Espírito-Santo, João Bispo, João Guedes, Jorge Mimoso, Hugo Palmeiro, Rui Baptista Gonçalves, Hugo Vinhas
Rev Port Cardiol. 2024;43:167-74
3092
Acesso de texto completo
3066
Clips on the X-ray: Expect the unexpectedRita Justo Pereira, Mariana Lemos, Isabel Sampaio Graça, Graça Nogueira, Rui Anjos
Rev Port Cardiol. 2024;43:95-6
3066
Acesso de texto completo
2909
Home- versus centre-based EXercise InTervention in patients with Heart Failure (EXIT-HF trial): A pragmatic randomized controlled trialCristine Schmidt, Sandra Magalhães, Priscilla Gois Basilio, Marisol Gouveia, Manuel Teixeira, Cláudio Santos, Aida Isabel Tavares, João Pedro Ferreira, ... Mário Santos
Rev Port Cardiol. 2024;43:149-58
2909
Acesso de texto completo
2900
The culprit of uncontrolled hypertension: A case of monoamine oxidase inhibitor and clonidine interactionLinfang Deng, Lihua Shi, Xiaolan Ye
Rev Port Cardiol. 2024;43:223-4
2900
Acesso de texto completo
2898
Effectiveness and safety of non-invasive ventilation in the management of cardiogenic shockLuna Carrillo-Aleman, Angel Andres Agamez-Luengas, Miguel Guia, Ana Renedo-Villarroya, Nuria Alonso-Fernández, Laura Lopez-Gomez, Pablo Bayoumy-Delis, Juan M. Sanchez-Nieto, ... Andrés Carrillo-Alcaraz
Rev Port Cardiol. 2024;43:259-73
2898
Acesso de texto completo
2892
PrOgnosis in Pulmonary Embolism (PoPE): 30-Day mortality risk score based on five admission parametersFilipa Gerardo, Daniel Faria, Pedro Silvério António, João Baltazar Ferreira, Marco Beringuilho, Hilaryano Ferreira, Inês Fialho, Inês Miranda, ... João B. Augusto
Rev Port Cardiol. 2024;43:1-8
2892
Acesso de texto completo
2864
High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in PortugalKashish Zehra Manjee, Danish Hassan
Rev Port Cardiol. 2024;43:299-300
2864
Acesso de texto completo
2812
Pulmonary arterial hypertension: Navigating the pathways of progress in diagnosis, treatment, and patient careMiguel Azaredo Raposo, Daniel Inácio Cazeiro, Tatiana Guimarães, Nuno Lousada, Céline Freitas, Joana Brito, Susana Martins, Catarina Resende, ... Rui Plácido
Rev Port Cardiol. 2024;43:699-719
2812
Acesso de texto completo
2789
Cirrhotic cardiomyopathy: Pathogenesis, clinical features, diagnosis, treatment and prognosisFrancisca Almeida, Alexandra Sousa
Rev Port Cardiol. 2024;43:203-12
2789
Acesso de texto completo
2665
Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in EuropeMargarida Temtem, Maria Isabel Mendonça, Marina Santos, Débora Sá, Francisco Sousa, Sónia Freitas, Sofia Borges, Eva Henriques, ... Roberto Palma Reis
Rev Port Cardiol. 2024;43:437-44
2665
Acesso de texto completo
2602
Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?Joana Delgado-Silva
Rev Port Cardiol. 2024;43:175-6
2602
Acesso de texto completo
2553
World Heart Federation Cholesterol Roadmap: The Portuguese caseAna Abreu, Hélder Dores, Lino Gonçalves, Fátima Franco, Conceição Silveira, Gonçalo Proença, Ana Teresa Timóteo, Nuno Cardim, ... Fausto J. Pinto
Rev Port Cardiol. 2024;43:633-41
2553
Acesso de texto completo
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.